Registered entities
Alx Oncology Inc.
Reg. No. 472849014United States
ALX ONCOLOGY LIMITED
Reg. No. 558988Belgium
ALX ONCOLOGY HOLDINGS INC
Reg. No. 1810182United States
Innovation
19 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 4,751 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 8 |
| 2021 | 9 |
| 2022 | 13 |
| 2023 | 12 |
| 2024 | 12 |
| 2025 | 11 |
| 2026 | 3 |
Investor mix
12 investors on record; lead investors include Vivo Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 58% |
| Private equity | 3 | 25% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 1 | 8% |